Zoetis Inc. Loss Contingency, Receivable, Current
Zoetis Inc. (ZTS) had Loss Contingency, Receivable, Current of $14.00 million as of 2013-09-29, per its 10-Q filed 2013-11-13.
Discontinued › Notes › Commitment and Contingencies › Loss Contingency
us-gaap:LossContingencyReceivableCurrent · last filed 2013-11-13
- 2013-09-29: Loss Contingency, Receivable, Current $14.00M.
- 2013-06-30: Loss Contingency, Receivable, Current $14.00M.
| Period end | Loss Contingency, Receivable, Current |
|---|---|
| 2013-09-29 | $14.00M 10-Q · filed 2013-11-13 |
| 2013-06-30 | $14.00M 10-Q · filed 2013-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |